- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00481260
Characteristics of Hgb C Carriers in Northern Israel and Clinical Features Among Hgb Homozygous
Hgb C is an hemoglobinopathy quite rare in Israel. The clinical status of patients that are diagnosed as homozygous to this disease is quite benign but not study in large groups.
Also the characteristics of carriers and the incidence in northern Israel were a large arab population lives, was not study. The results of this study can be useful for screening purpose in a area were another hemoglobinopathies are frequent.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hgb C is an hemoglobinopathy quite rare in Israel. The clinical status of patients that are diagnosed as homozygous to this disease is quite benign but not study in large groups.
Also the characteristics of carriers and the incidence in northern Israel were a large arab population lives, was not study. The results of this study can be useful for screening purpose in a area were another hemoglobinopathies are frequent.
The study will record the clinical characteristics of the homozygous Hgb C patients and the hematology characteristics of all the heterozygous carriers detected in northern Israel
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Afula, Israel, 18101
- Pediatric Hematology Unit - HaEmek Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients diagnosed as homozygous for Hgb C disease or double heterozygous in combination to other abnormal hemoglobin, and all the carriers detected in the hematology laboratory during the screening for abnormal hemoglobins in northern Israel
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: luci Zalman, Phd, Hematology Laboratory - HaeEmek Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5100706.EMC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hgb C Hemoglobinopathy
-
National Institute of Diabetes and Digestive and...CompletedBeta Thalassemia | HemoglobinopathyUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteTerminatedSickle Cell Anemia | Thalassemia | HemoglobinopathyUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...TerminatedSickle Cell Anemia | Thalassemia | HemoglobinopathyUnited States
-
Dokuz Eylul UniversityEge UniversityCompletedMMP9 | TIMP1 | MMP9 -1562 C/T | TIMP1 372 T/CTurkey
-
Tripep ABInovio PharmaceuticalsUnknownChronic Hepatitis C Virus InfectionSweden
-
Johann Wolfgang Goethe University HospitalCompleted
-
Hadassah Medical OrganizationXTL BiopharmaceuticalsWithdrawnChronic Hepatitis C Virus InfectionIsrael
-
Hadassah Medical OrganizationUnknownChronic Hepatitis C Virus InfectionIsrael
-
National Heart, Lung, and Blood Institute (NHLBI)Children's National Research InstituteRecruitingSickle Cell Disease | Thalassemia | HemoglobinopathyUnited States
-
Meir Medical CenterCompletedDeveloping Novel Technique of Measuring C/D Ratio From Digital Stereo Optic Disc Images | Intraobserver Reproducibility of C/D Measurements | Interobserver Variability of C/D Measurements
Clinical Trials on Medical history and basic laboratory analysis
-
HaEmek Medical Center, IsraelCompleted
-
Sohag UniversityNot yet recruitingAcute Necrotizing EncephalopathyEgypt
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMalignant NeoplasmUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Diabetes Foundation, IndiaJohns Hopkins University; National Diabetes Obesity and Cholesterol FoundationRecruiting
-
National Cancer Institute (NCI)Not yet recruitingStage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerCanada